NCT01611883View on ClinicalTrials.gov

A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541)

PHASE4CompletedINTERVENTIONAL

Enrollment

152

Participants

Timeline

Start Date

July 2, 2012

Primary Completion Date

January 16, 2014

Study Completion Date

January 16, 2014

Conditions

Hypercholesterolemia

Interventions

DRUG

Ezetimibe

10 mg oral dose once daily for 24 weeks

DRUG

Placebo

Placebo to match ezetimibe orally once daily for 24 weeks.

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT01611883 - A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541) | Biotech Hunter | Biotech Hunter